Modulation of diabetes-induced palate defects by maternal immune stimulation

Anatomical Record

Volumn 292, Issue 2, 2009, Pages 271-276

  Hrubec, Terry C ^a   Toops, Kimberly A ^b   Holladay, Steven D ^b  

^a EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Development; Diabetes; Maternal immune stimulation; Palate; Teratology

Indexed keywords

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CLEFT PALATE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FREUND'S ADJUVANT; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; INFANT, NEWBORN; INTERFERON-GAMMA, RECOMBINANT; MATERNAL-FETAL EXCHANGE; MAXILLOFACIAL ABNORMALITIES; MICE; MICE, INBRED ICR; PALATE; PREGNANCY; PREGNANCY IN DIABETICS; SIGNAL TRANSDUCTION;

ANIMALIA; MUS;

EID: 59949088739     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20836     Document Type: Article

References (38)

1. Blaustein FM, Felle R, Rosenzweig S. 1971. Effect of ACTH and adrenal hormones on cleft palate frequency in CD-1 mice. J Dent Res 50:609-612.
2. Carstens MH. 2004. Neural tube programming and craniofacial cleft formation. I. The neuromeric organization of the head and neck. Eur J Paediatr Neurol 8:181-210.
3. Cederberg J, Picard JJ, Eriksson UJ. 2003. Maternal diabetes in the rat impairs the formation of neural-crest derived cranial nerve ganglia in the offspring. Diabetologia 46:1245-1251.
4. Degitz SJ, Morris D, Foley GL, Francis BM. 1998. Role of TGF-beta in RA-induced cleft palate in CD-1 mice. Teratology 58:197-204.
5. Diewert VM. 1981. Correlation between alterations in Meckel's cartilage and induction of cleft palate with beta-aminoproprionitrile in the rat. Teratology 24:43-52.
6. Eriksson UJ, Cederberg J, Wentzel P. 2003. Congenital malformations in offspring of diabetic mothers - animal and human studies. Rev Endocr Metab Disord 4:79-93.
7. Ewart-Toland A, Yankowitz J, Winder A, Imagire R, Cox VA, Aylsworth AS, Golabi M. 2000. Oculoauriculovertebral abnormalities in children of diabetic mothers. Am J Med Genet 90:303-309.
8. Fein A, Kostina E, Savion S, Orenstein H, Shepshelovich J, Ornoy A, Torchinsky A, Toder V. 2001. Expression of tumor necrosis factor-a in the pregnant uterus of diabetic mice: effect of maternal immunopotentiation. Am J Reprod Immunol 46:161-168.
9. Fein A, Magid N, Savion S, Orenstein H, Shepshelovich J, Ornoy A, Torchinsky A, Toder V. 2002. Diabetes teratogenicity in mice is accompanied with distorted expression of TGFβ2 in the uterus. Teratog Carcinog Mutagen 22:59-71.
10. Fine EL, Horal M, Chang TI, Fortin G, Loeken MR. 1999. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes 48:2454-2462.
11. Goldman AS, Baker L, Piddington R, Marx B, Herold R, Egler J. 1985. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci USA 82:8227-8231.
12. Hill CA, Reeves RH, Richtsmeier JT. 2007. Effects of aneuploidy on skull growth in a mouse model of Down syndrome. J Anat 210:394-405.
13. Hilliard SA, Yu L, Gu S, Zhang Z, Chen YP. 2005. Regional regulation of palatal growth and patterning along the anterior-posterior axis in mice. J Anat 207:655-667.
14. Holladay SD, Sharova LV, Punareewattana K, Hrubec TC, Gogal RM, Jr, Prater MR, Sharova AA. 2002. Maternal immune stimulation in mice decreases fetal malformations caused by teratogens. Int Immunopharmacol 2:325-332.
15. Holladay SD, Sharova LV, Smith BJ, Gogal RM, Jr, Ward DL, Blaylock BL. 2000. Non-specific stimulation of the maternal immune system. I. Effects on teratogen-induced fetal malformations. Teratology 62:413-419.
16. Hrubec TC, Prater MR, Toops KA, Holladay SD. 2006b. Reduction in diabetes induced craniofacial defects by maternal immune stimulation. Birth Defects Res B Dev Reprod Toxicol 77:1-9.
17. Hrubec TC, Yan M, Ye K, Salafia CM, Holladay SD. 2006a. Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma. Anat Rec A Discov Mol Cell Evol Biol 288:1303-1309.
18. Hrubec TC, Punareewattana K, Prater MR, Holladay SD. 2005. Reduction of teratogen induced birth defects in mice: role of maternal immune stimulation. Curr Top Toxicol 2:33-40.
19. Janssen PA, Rothman I, Schwartz SM. 1996. Congenital malformations in newborns of women with established and gestational diabetes in Washington State. 1984-1991. Paediatr Perinat Epidemiol 10:52-63.
20. Kanzler B, Foreman RK, Labosky PA, Mallo M. 2000. BMP signaling is essential for development of skeletogenic and neurogenic cranial neural crest. Development 27:1095-1104.
21. Liu W, Sun X, Braut A, Mishina Y, Behringer RR, Mina M, Martin JF. 2005. Distinct function for Bmp signaling in lip and palate fusion in mice. Development 132:1453-1461.
22. Nomura T, Hata S, Kusafuka T. 1990. Suppression of developmental anomalies by maternal macrophages in mice. J Exp Med 172: 1325-1330.
23. Okano J, Suzuki S, Shiota K. 2006. Regional heterogeneity in the developing palate: morphological and molecular evidence for normal and abnormal palatogenesis. Congenit Anom (Kyoto) 46:49-54.
24. Prater MR, Strahl ED, Zimmerman KL, Ward DL, Holladay SD. 2004. Reduced birth defects caused by maternal immune stimulation in methylnitrosourea-exposed mice: association with placental improvement. Birth Defects Res A Clin Mol Teratol 70:862-869.
25. Punareewattana K, Holladay SD. 2004. Immunostimulation by complete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, or interferon-γ reduces severity of diabetic embryopathy in ICR mice. Birth Defects Res A Clin Mol Teratol 70:20-27.
26. Punareewattana K, Sharova LV, Li W, Ward DL, Holladay SD. 2003. Reduced birth defects caused by maternal immune stimulation may involve increased expression of growth promoting genes and cytokine GM-CSF in the spleen of diabetic ICR mice. Int Immunopharmacol 3:1639-1655.
27. Ricks JE, Ryder VM, Bridgewater LC, Schaalje B, Seegmiller RE. 2002. Altered mandibular development precedes the time of palate closure in mice homozygous for disproportionate micromelia: an oral clefting model supporting the Pierre-Robin sequence. Teratology 65:116-120.
28. Rosenzweig S, Blaustein FM. 1971. Cleft palate in CD-1 mice from restraint and deprivation of food and water. J Dent Res 50:503.
29. Sato TJ. 1994. Analysis of palatogenesis in the mouse with exencephaly induced by cadmium chloride. Congenit Anom (Kyoto) 34:53-63.
30. Savion S, Gidon-Dabush S, Fein A, Torchinsky A, Toder V. 2004. Diabetes teratogenicity is accompanied by alterations in macrophages and T cell subpopulations in the uterus and lymphoid organs. Int Immunopharmacol 4:1319-1327.
31. Sharova LV, Gogal RM, Jr, Sharova AA, Crisman MV, Holladay SD. 2002. Immune stimulation in urethane-exposed pregnant mice increases expression of level of spleen leukocyte genes for TGFb3, GM-CSF and other cytokines that may play a role in reduced chemical-induced birth defects. Int Immunopharmacol 2:1477-1489.
32. Sharova LV, Sura P, Smith BJ, Gogal RM, Jr, Sharov AA, Ward DL, Holladay SD. 2000. Non-speci.c stimulation of the maternal immune system. I. Effects on fetal gene expression. Teratology 62:420-428.
33. Silbermann M, Levitan S. 1979. Corticosteroid-induced mandibular growth retardation and palatal malformation in the ICR mouse fetus. J Anat 128(Part 4):747-765.
34. Spilson SV, Kim HJ, Chung KC. 2001. Association between maternal diabetes mellitus and newborn oral cleft. Ann Plast Surg 47:477-481.
35. Takagi TN, Matsui KA, Yamashita K, Ohmori H, Yasuda M. 2000. Pathogenesis of cleft palate in mouse embryos exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratog Carcinog Mutagen 20:73-86.
36. Torchinsky A, Toder V, Savion S, Shepshelovich J, Orenstein H, Fein A. 1997. Immunostimulation increases the resistance of mouse embryos to the teratogenic effect of diabetes mellitus. Diabetologia 40:635-640.
37. Yamada T, Mishima K, Fujiwara K, Imura H, Sugahara T. 2006. Cleft lip and palate in mice treated with 2,3,7,8-tetrachlorodibenzo-pdioxin: a morphological in vivo study. Congenit Anom (Kyoto) 46:21-25.
38. Yasuda M, Sato TJ, Sumida H. 1991. Exencephalic mouse fetuses are resistant to cleft palate induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratology 43:445.